Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 825
  • Home
  • Print this page
  • Email this page


 
   Table of Contents      
LETTER TO THE EDITOR
Year : 2018  |  Volume : 66  |  Issue : 1  |  Page : 174-175

Comment on: “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”


Department of Vitreoretina and Uvea, ICARE Eye Hospital and Post Graduate Institute, Noida, Uttar Pradesh, India

Date of Web Publication28-Dec-2017

Correspondence Address:
Dr. Koushik Tripathy
Department of Vitreoretina and Uvea, ICARE Eye Hospital and Post Graduate Institute, E3A, Sector-26, Noida - 201 301, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_733_17

Rights and Permissions

How to cite this article:
Tripathy K. Comment on: “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”. Indian J Ophthalmol 2018;66:174-5

How to cite this URL:
Tripathy K. Comment on: “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”. Indian J Ophthalmol [serial online] 2018 [cited 2019 Jun 16];66:174-5. Available from: http://www.ijo.in/text.asp?2018/66/1/174/221814



Sir,

I read with interest the case report on the closure of a macular hole over a serous retinal pigment epithelial detachment (PED) with intravitreal bevacizumab.[1] I want to humbly discuss a few facts.

The role of anti-vascular endothelial growth factor (anti-VEGF) agents in serous PED without subretinal or intraretinal fluid or active choroidal neovascular membrane/idiopathic polypoidal choroidal vasculopathy may require further research. In the present case,[1] the shallow subretinal fluid at one margin of the macular hole could have been related to the macular hole itself or the mechanical effect of the high PED. In such a scenario, fundus fluorescein angiogram and indocyanine green angiogram would add significant scientific value and justification for the use of bevacizumab in this case, if they are available. Furthermore, we need to consider the fact that intravitreal anti-VEGF agents can cause retinal pigment epithelial tears [2] in cases of high serous PEDs. The rare but potentially blinding complications of intravitreal anti-VEGF agents such as endophthalmitis [3] and retinal detachment should be kept in mind. The goal of management with intravitreal bevacizumab in the presented case [1] may need elucidation. A history of systemic or local steroid use is also relevant in the presented case, as central serous chorioretinopathy, though unlikely in a 73 year old, needs to be ruled out.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Storch MW, Hoerauf H. Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment. Indian J Ophthalmol 2017;65:632-3.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Tripathy K, Chawla R, Kumar V, Sharma YR, Venkatesh P. A 56-year-old male with unilateral painless diminution of vision. Oman J Ophthalmol 2016;9:119.  Back to cited text no. 2
[PUBMED]  [Full text]  
3.
Kumar A, Tripathy K, Chawla R. High Alert on intraocular use of bevacizumab (Avastin ®) in India: An Indian ophthalmologist's perspective. Natl Med J India 2017; In press.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed504    
    Printed0    
    Emailed0    
    PDF Downloaded70    
    Comments [Add]    

Recommend this journal